Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 0.83 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.77 |
| ▸ | MEN1 | O00255 | 8/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.77 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.77 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.77 |
| ▸ | XDH | P47989 | 6/20 | 0.77 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 0.77 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 0.77 |
| ▸ | CA12 | O43570 | 4/20 | 0.77 |
| ▸ | PPARG | P37231 | 4/20 | 0.77 |
| ▸ | CA7 | P43166 | 4/20 | 0.77 |
| ▸ | CA2 | P00918 | 3/20 | 0.77 |
| ▸ | CA4 | P22748 | 3/20 | 0.77 |
| ▸ | MAOA | P21397 | 6/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laricytrin SCHEMBL29929477 | 1.00 | ABCB1 (0.83) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Syringetin SCHEMBL29929167 | 0.96 | ABCB1 (0.85) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Syringetin SCHEMBL810981 | 0.96 | ABCB1 (0.85) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL19249162 | 0.91 | ABCB1 (0.78) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL30255771 | 0.91 | ABCB1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL4034698 | 0.91 | ABCB1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL12640011 | 0.88 | NOX4 (0.79) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Mearnsetin SCHEMBL3690508 | 0.88 | ABCB1 (0.81) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Myricetin SCHEMBL3503992 | 0.87 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Myricetin SCHEMBL19302 | 0.87 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20260090573-A1 | REDUCED-SUGAR FRUIT JUICE AND FRUIT MUST | INNOVATIVE STRATEGIC DESIGN, LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12490759-B2 | Reduced-sugar fruit juice and fruit must | INNOVATIVE STRATEGIC DESIGN, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4649129-A1 | PRESSURE ASSISTED DIAFILTRATION SEPARATION METHODS AND SYSTEMS | Altr Fltr Inc. (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20250197898-A1 | ISOTHIOCYANATE CONTAINING BRASSICACEAE PRODUCTS AND METHOD OF PREPARATION THEREOF | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-06-19 | — | — | US | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250134851-A1 | ALTERNATIVE NOVEL MATERIAL TO BOTULINUM NEUROTOXIN AND PREPARATION METHOD THEREOF | ACTIVON CO., LTD. (KR) | 2025-05-01 | — | — | US | disclosed |
| US-20250120399-A1 | METHODS AND COMPOSITIONS FOR ALTERING METABOLITES IN VITIS SPP. AND PREVENTING PESTS AND PATHOGENS | IMPELLO BIOSCIENCES, INC. | 2025-04-17 | — | — | US | disclosed |
| US-12227780-B2 | Isothiocyanate containing Brassicaceae products and method of preparation thereof | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-02-18 | — | — | US | disclosed |
| US-10682333-B2 | Composition for inhibiting formation of SNARE complex, containing myricetin derivatives | Research & Business Foundation Sungkyunkwan University (KR) | 2020-06-16 | — | — | US | disclosed |
| US-20190175544-A1 | Pharmaceutical Compositions and Methods for Countering Chemotherapy Induced Cardiotoxicity | SCT II LLC (US) | 2019-06-13 | — | — | US | disclosed |
| US-20180222878-A1 | COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES | Research & Business Foundation Sungkyunkwan University (KR) | 2018-08-09 | — | — | US | disclosed |
| US-20180222878-A1 | COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES | Research & Business Foundation Sungkyunkwan University (KR) | 2018-08-09 | — | — | US | disclosed |
| EP-3329913-A1 | COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES | Research & Business Foundation Sungkyunkwan University (KR) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017136774-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | STEM CELL THERANOSTICS, INC. (US) | 2017-08-10 | — | — | WO | disclosed |
| US-20170224654-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | STEM CELL THERANOSTICS, INC. (US) | 2017-08-10 | — | — | US | disclosed |
| US-20170224654-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | STEM CELL THERANOSTICS, INC. (US) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ABCB1 719/4885CYP1A2 3865/4885MEN1 1711/4885 |
| US-10682333-B2 | Composition for inhibiting formation of SNARE complex, containing myricetin derivatives | VAMP7, FLOT1, SNAP29 | ABCB1 673/4885CYP1A2 2548/4885MEN1 598/4885 |
| US-20190175544-A1 | Pharmaceutical Compositions and Methods for Countering Chemotherapy Induced Cardiotoxicity | RDX, TNNT2, CHLSN | ABCB1 106/4885CYP1A2 300/4885MEN1 1453/4885 |
| US-20170224654-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | RDX, TNNT2, CHLSN | ABCB1 106/4885CYP1A2 300/4885MEN1 1453/4885 |
| US-20250134851-A1 | ALTERNATIVE NOVEL MATERIAL TO BOTULINUM NEUROTOXIN AND PREPARATION METHOD THEREOF | SNAP29, VAMP7, ACHE | ABCB1 4686/4885CYP1A2 4343/4885MEN1 105/4885 |
| US-20260090573-A1 | REDUCED-SUGAR FRUIT JUICE AND FRUIT MUST | KCNN2, KCNN1, PROC | ABCB1 3785/4885CYP1A2 4521/4885MEN1 946/4885 |
| US-20250120399-A1 | METHODS AND COMPOSITIONS FOR ALTERING METABOLITES IN VITIS SPP. AND PREVENTING PESTS AND PATHOGENS | VAT1, PTMS, PSPH | ABCB1 4818/4885CYP1A2 1911/4885MEN1 3166/4885 |
| US-20180222878-A1 | COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES | VAMP7, FLOT1, SNAP29 | ABCB1 673/4885CYP1A2 2548/4885MEN1 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.